Loading...

Financial Statements

Applied DNA Sciences Inc

Applied DNA Sciences Inc (APDN)

Industrials

Income Statement

Download APDN income statement Download APDN income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Earnings Per Share Basic 1.20-1.80-1.80-0.74-1.51-0.97-0.63-0.51-0.49-0.40
Net Profit Margin 13.36-15.22-10.85-3.86-8.69-4.80-1.32-2.91-2.71-3.00
Earnings Per Share Diluted 1.20-1.80-1.80-0.74-1.51-0.97-0.63-0.51-0.49-0.40
Revenue 0.300.520.971.852.042.729.014.194.753.90
Weighted Average Shares Outstanding 4.585.617.8810.6612.4013.7921.4924.0827.3830.11
Gross Profit 0.230.520.971.852.042.728.623.023.672.70
Weighted Average Shares Outstanding (Diluted) 4.195.016.289.6011.7313.5218.9423.6926.3829.50
Sales, General and Administrative Expense 6.587.198.397.6211.2013.2513.4110.8113.3211.04
Dividend per Share ----------
Operating Income -6.90-7.12-8.06-6.51-10.18-12.27-7.85-12.20-12.82-11.65
Gross Margin 0.791.001.001.001.001.000.960.720.770.69
Earnings before Tax 3.95-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
EBITDA Margin 18.79-12.97-7.94-3.34-8.59-4.63-1.26-2.74-2.57-2.85
Net Income 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
EBIT Margin 17.37-13.69-8.32-3.51-8.69-4.80-1.32-2.91-2.71-2.99
Net Income - Discounted ops ----------
Profit Margin 13.36-15.21-10.85-3.85-8.69-4.80-1.32-2.91-2.71-3.00
Preferred Dividends ----------
Free Cash Flow margin -0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
R&D Expenses 0.140.080.270.430.691.302.583.702.282.75
Interest Expense 1.180.792.460.64-0.000.010.02-0.01-0.000.01
Earnings Before Tax Margin 13.37-15.22-10.85-3.86-8.69-4.80-1.32-2.91-2.71-3.00
Consolidated Income 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
EBIT 5.13-7.12-8.06-6.51-17.69-13.06-11.86-12.19-12.86-11.68
EBITDA 5.55-6.75-7.69-6.19-17.48-12.61-11.37-11.48-12.23-11.14
Income Tax Expense 0.00---------
Operating Expenses 7.137.649.038.3612.2114.9916.4815.2216.4914.34
Cost of Revenue 0.06-----0.381.171.081.21
Net Income Com 3.94-7.91-10.52-7.15-17.69-13.07-11.88-12.18-12.86-11.69
Net Income - Non-Controlling int ----------

Balance Sheet Statement

Download APDN income statement Download APDN income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total current liabilities 3.252.794.500.591.123.882.674.081.302.82
Other Liabilities ----0.150.58-0.041.620.351.86
Long-term debt -0.22-------1.59
Cash and cash equivalents 0.220.032.770.766.411.457.384.543.021.72
Total debt 2.412.043.73--1.80---1.59
Cash and short-term investments 0.220.032.770.766.411.457.384.543.021.72
Deferred revenue ----0.150.580.282.740.351.86
Inventories -------0.300.330.22
Tax Liabilities ----------
Goodwill and Intangible Assets 1.000.640.27-0.420.331.881.811.331.15
Deposit Liabilities ----------
Tax assets ----------
Total non-current liabilities -0.22--2.641.100.321.12-2.06
Total current assets 1.171.170.470.251.171.144.024.211.911.63
Total liabilities 3.253.014.500.593.764.972.995.201.304.88
Payables 0.840.970.770.590.971.492.712.460.940.97
Other comprehensive income ----------
Short-term investments ----------
Retained earnings (deficit) -143.43-151.34-161.86-169.01-186.69-199.76-211.64-223.82-236.67-248.37
Property, Plant & Equipment Net 0.010.000.090.210.700.580.570.790.520.42
Total non-current assets -0.22--2.641.100.321.12-2.06
Other Assets 0.070.150.050.040.120.08-1.27-1.400.310.57
Net Debt 2.192.020.96-0.76-6.410.35-7.38-4.54-3.02-0.14
Investments ----------
Total shareholders equity -1.75-1.60-1.000.764.62-1.4712.5710.376.860.75
Total assets 1.511.413.501.358.373.5115.5515.578.155.63
Long-term investments ----------
Receivables 0.050.060.210.300.670.835.437.912.591.49
Short-term debt 2.411.823.73--1.80----

Cash Flow Statement

Download APDN income statement Download APDN income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Insurance (repayment) of debt ----------
Net Cash/Marketcap -0.00-0.00-0.000.000.00-0.000.000.000.000.00
Insurance (buybacks) of shares ----------
Depreciation & Amortization 0.420.370.370.310.210.440.490.710.630.55
Dividend payments ----------
Operating Cash Flow -2.47-2.46-3.76-3.96-7.87-8.51-6.97-9.90-7.48-6.92
Acquisitions and disposals -----0.58--1.50---
Free Cash Flow -2.47-2.46-3.85-4.12-8.51-8.74-7.32-10.56-7.62-7.18
Net cash flow / Change in cash 0.08-0.202.73-2.025.64-4.975.92-2.83-1.52-1.30
Effect of forex changes on cash ----------
Financing Cash Flow 2.552.266.582.1014.733.7815.027.846.115.88
Investment purchases and sales ----------
Capital Expenditure ---0.09-0.16-0.64-0.23-0.35-0.67-0.15-0.27
Stock-based compensation 3.393.802.931.951.522.034.022.043.261.36
Investing Cash Flow ----------

Retained Earning Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Retained Earnings (Previous Year) --143-151-162-169-187-200-212-224-237
Net Income 4-8-11-7-18-13-12-12-13-12
Stock Dividends -147---------
Divident Paid ----------
Retained Earnings -143-151-162-169-187-200-212-224-237-248

PPE Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Year 2009201020112012201320142015201620172018
Gross PPE -000011111
Annual Depreciation 0-0001001-00
Capital Expenditure ---0-0-1-0-0-1-0-0
Net PPE 0000111110

Intangible and Goodwill Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Intangible and Goodwill (Previous Year) -110-00221
New Purchases ----------
Intangible and Goodwill 110-002211

Applied DNA Sciences Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Applied DNA Sciences Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.